Extending the diabetic retinopathy screening interval beyond 1 year: systematic review (Q36475523)

14 August 2017

1 reference

4 February 2021

1 reference

PubMed publication ID

25586713

title

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review (English)

1 reference

14 August 2017

1 reference

30 June 2019

1 reference

30 June 2019

1 reference

4 February 2021

1 reference

7

1 reference

14 August 2017

Sian Taylor-Phillips

1

0 references

Hema Mistry

object named as

Hema Mistry

2

0 references

author name string

Rachael Leslie

3

1 reference

14 August 2017

Dan Todkill

4

1 reference

14 August 2017

Alexander Tsertsvadze

5

1 reference

14 August 2017

Martin Connock

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

13 January 2015

1 reference

British Journal of Ophthalmology

14 August 2017

1 January 2016

7 references

13 March 2019

14 March 2019

24 March 2019

25 April 2019

17 June 2019

30 June 2019

4 February 2021

8 references

14 August 2017

13 March 2019

14 March 2019

24 March 2019

25 April 2019

17 June 2019

30 June 2019

4 February 2021

100

1 reference

14 August 2017

1

1 reference

14 August 2017

105-114

1 reference

Creative Commons Attribution-NonCommercial

14 August 2017

7 references

13 March 2019

14 March 2019

24 March 2019

25 April 2019

17 June 2019

30 June 2019

4 February 2021

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Prognosis Research Strategy (PROGRESS) 3: prognostic model research

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

A simple risk stratification for time to development of sight-threatening diabetic retinopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy by Aspelund et al. (2011) Diabetologia 54:2525-2532.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Diabetic retinopathy--screening and management by Australian GPs.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Everything you always wanted to know about evaluating prediction models (but were too afraid to ask).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Diabetic retinopathy screening: a systematic review of the economic evidence

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Identification of independent risk factors for the development of diabetic retinopathy requiring treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Economic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: a community-based study in Kinmen, Taiwan

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

The English national screening programme for sight-threatening diabetic retinopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Biennial eye screening in patients with diabetes without retinopathy: 10-year experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Screening and prevention of diabetic blindness.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Cost-effectiveness of strategies for detecting diabetic retinopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Predicting the risk of diabetic retinopathy in type 2 diabetic patients.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Factors associated with follow-up eye examinations among persons with diabetes

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

The case for biennial retinopathy screening in children and adolescents

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

The evaluation of screening policies for diabetic retinopathy using simulation.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

New blindness in diabetes reduced by more than one-third in Stockholm County

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4717369

Risk stratification for diabetic eye screening

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2014-305938

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2014-305938

Screening for diabetic retinopathy. Initiation and frequency

21 January 2018

1 reference

12 December 2020

Diabetic retinopathy screening

1 reference

12 December 2020

Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme

1 reference

12 December 2020

1 reference

12 December 2020

Individualized optimization of the screening interval for diabetic retinopathy: a new model

1 reference

12 December 2020

10.1136/BJOPHTHALMOL-2014-305938

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

25586713

1 reference